XORTX Therapeutics Inc (XRTX) — Cash Flow Quality Index

Latest as of December 2024: -7.23x

XORTX Therapeutics Inc (XRTX) has a Cash Flow Quality Index of -7.23x as of December 2024. Operating cash flow of CA$-886.41K is below net income of CA$122.53K, suggesting accrual-heavy earnings not yet converted to cash. Explore XORTX Therapeutics Inc (XRTX) cash conversion ratio to assess how effectively this company generates cash.

Cash Flow Quality Index

-7.23x

Operating CF / Net Income

Operating Cash Flow

CA$-886.41K

CAD

Net Income

CA$122.53K

CAD

Data as of

Dec 2024

Most recent filing

Annual Cash Flow Quality Index for XORTX Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for XORTX Therapeutics Inc. For live market cap and the full company financial profile, see XRTX market cap.

Year	Quality Index	Operating CF (CAD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.